We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Roche and Trimeris, Inc. provided an update on the companies' development plans for administration of FUZEON (enfuvirtide) with a needle-free injection device (Biojector 2000, B2000).
Northstar Neuroscience Inc. said that its key clinical trial, which uses a brain implant to help stroke victims regain control of hands and arms, is one quarter ahead of schedule.
Cardiogenesis Corporation, a leading developer of surgical products and accessories used in angina-relieving procedures, announced that the company has received CE Mark approval for marketing its advanced combination delivery system.
Ambulatory care centers in New Jersey were identified by a state official yesterday as the "biggest abusers" when it comes to using reprocessed single-use medical devices, and federal officials admitted they lack the resources to monitor such medical sites.
Pfizer announced Oct. 9 it will purchase PowderMed, a UK company that developed particle-mediated epidermal delivery technology, which boosts the immune system by shooting microscopic DNA-coated gold particles into the skin.
An editorial on the American College of Cardiology (ACC) website supports recent studies showing that drug-eluting stents may pose a greater risk to patients than previously thought.
Medtronic Vascular violated federal regulations by failing to submit an interim postmarket surveillance report on time, the FDA said in a Sept. 27 warning letter.